2011
DOI: 10.1007/s12663-011-0262-5
|View full text |Cite
|
Sign up to set email alerts
|

Nevoid Basal Cell Carcinoma Syndrome: A Case Report and Review

Abstract: Nevoid basal cell carcinoma syndrome, a rare autosomal dominant disorder, comprises of a number of abnormalities such as multiple nevoid basal cell carcinomas, skeletal abnormalities and multiple keratocystic odontogenic tumors. Diagnosis may be difficult because of the variability of expressivity and different ages of onset for different traits of this disorder. The dental clinician may be the first to encounter and identify this syndrome, when the multiple cysts like radiolucencies are discovered on panorami… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0
1

Year Published

2015
2015
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(8 citation statements)
references
References 15 publications
0
7
0
1
Order By: Relevance
“…For this, radiographic exams, which have a low cost, must be used [14]. As the syndrome is of autosomal dominant inheritance, offspring have 50% risk of being affected [1,14,22]. However, some syndromic patients can present a new spontaneous mutation [23,24], with no history of an affected family member [15].…”
Section: Discussionmentioning
confidence: 99%
“…For this, radiographic exams, which have a low cost, must be used [14]. As the syndrome is of autosomal dominant inheritance, offspring have 50% risk of being affected [1,14,22]. However, some syndromic patients can present a new spontaneous mutation [23,24], with no history of an affected family member [15].…”
Section: Discussionmentioning
confidence: 99%
“…One source of diagnostic criteria for NBCCS establishes two major or one major and two minor diagnostic criteria [5]. The variability in expressivity and the difference in age of onset of the different characteristics of the disorder may cause difficulty in diagnosing patients [6]. Diagnosis can be confirmed by molecular genetic testing with the identification of a heterozygous germline pathogenic variant in PTCH1 or SUFU [3].…”
Section: Case Discussionmentioning
confidence: 99%
“…BCCs in GGS patients range in number from a few to many thousands of lesions, with the face, back and chest being the most commonly involved sites [ 8 ]. The highest incidence of BCCs in these individuals is between puberty and age 35, with increased sun exposure believed to be a risk factor [ 9 ].…”
Section: Discussionmentioning
confidence: 99%